Aspira Women’s Health (NASDAQ:AWH) Now Covered by StockNews.com

StockNews.com started coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a report published on Wednesday morning. The brokerage issued a hold rating on the stock.

Aspira Women’s Health Trading Up 3.1 %

Aspira Women’s Health stock opened at $0.77 on Wednesday. Aspira Women’s Health has a 1-year low of $0.67 and a 1-year high of $5.65. The company has a fifty day simple moving average of $0.82 and a 200 day simple moving average of $1.04. The company has a market cap of $12.87 million, a P/E ratio of -0.64 and a beta of 1.39.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. raised its stake in Aspira Women’s Health Inc. (NASDAQ:AWH) by 88.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 236,396 shares of the company’s stock after acquiring an additional 111,022 shares during the quarter. B. Riley Wealth Advisors Inc. owned about 1.90% of Aspira Women’s Health worth $352,000 at the end of the most recent reporting period. 12.19% of the stock is currently owned by institutional investors and hedge funds.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.